Management of Postoperative Hyponatremia Following Transsphenoidal Surgery

Postoperative hyponatraemia represents one of the most frequent and clinically significant complications after transsphenoidal surgery. It typically emerges between days 4 and 10 post-operatively and can range from asymptomatic mild sodium derangements to severe, symptomatic disturbances necessitating urgent intervention. Pathophysiological mechanisms span inappropriate antidiuretic hormone secretion resulting in water retention, cerebral salt wasting with natriuresis and hypovolaemia, or a combination of both. The risk is heightened in patients with pituitary stalk manipulation, transient diabetes insipidus followed by antidiuretic rebound, and those with comorbid cardiac or renal impairment. Management strategies are dictated by severity and underlying aetiology: fluid restriction remains first-line for mild, euvolaemic hyponatraemia, whereas hypertonic saline is reserved for severe or symptomatic cases. Sodium supplementation and cautious use of loop diuretics may aid natriuresis in salt-wasting scenarios. More recently, arginine vasopressin receptor antagonists have emerged as targeted therapy to promote free water excretion without significant electrolyte loss. Protocols now emphasise daily serum sodium monitoring until day 10, tailored fluid orders, and patient education on fluid intake after discharge. Early recognition and stratified treatment not only reduce length of hospital stay but also mitigate readmission rates and neurocognitive sequelae.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Management of Postoperative Hyponatremia Following Transsphenoidal Surgery publication trend

The graph below shows the total number of articles in management of postoperative hyponatremia following transsphenoidal surgery across all publications each year (not limited to Nature Index journals).

Technical terms

Hyponatraemia: A serum sodium concentration below 135 mmol/L, reflecting an imbalance between total body water and sodium content.

Transsphenoidal surgery: A minimally invasive approach to the pituitary gland accessed via the sphenoid sinus, commonly used for resection of pituitary adenomas and other sellar lesions.

Syndrome of inappropriate antidiuretic hormone secretion (SIADH): A condition characterised by excessive release of antidiuretic hormone, leading to water retention and dilutional hyponatraemia.

Cerebral salt wasting (CSW): A renal salt-wasting syndrome associated with intracranial pathology, resulting in hypovolaemia and hyponatraemia.

Arginine vasopressin receptor antagonists (vaptans): A class of medications that block renal V2 receptors to induce free water excretion (aquaresis) without substantial sodium loss.

References

1. Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center. Journal of Clinical Medicine (2014).
2. The management and outcome of hyponatraemia following transsphenoidal surgery: a retrospective observational study. Acta Neurochirurgica (2022).
3. Novel Nomograms to Predict Delayed Hyponatremia After Transsphenoidal Surgery for Pituitary Adenoma. Frontiers in Endocrinology (2022).
4. Impact of surgical factors on delayed hyponatremia in patients with nonfunctioning pituitary adenoma after endonasal endoscopic transsphenoidal procedure. Endocrine (2022).